INNOVIZ TECHNOLOGIES LTD (INVZ)

IL0011745804 - Common Stock

1.68  -0.16 (-8.7%)

Premarket: 1.68 0 (0%)

Fundamental Rating

4

Taking everything into account, INVZ scores 4 out of 10 in our fundamental rating. INVZ was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. While INVZ has a great health rating, there are worries on its profitability. INVZ is valued quite expensive, but it does show an excellent growth.



0

1. Profitability

1.1 Basic Checks

INVZ had negative earnings in the past year.
In the past year INVZ has reported a negative cash flow from operations.
In the past 5 years INVZ always reported negative net income.
INVZ had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of INVZ (-73.85%) is worse than 90.08% of its industry peers.
INVZ's Return On Equity of -115.10% is on the low side compared to the rest of the industry. INVZ is outperformed by 86.78% of its industry peers.
Industry RankSector Rank
ROA -73.85%
ROE -115.1%
ROIC N/A
ROA(3y)-50.97%
ROA(5y)-63.9%
ROE(3y)-66%
ROE(5y)-85.82%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for INVZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

INVZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
INVZ has more shares outstanding than it did 1 year ago.
There is no outstanding debt for INVZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -5.43, we must say that INVZ is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of INVZ (-5.43) is worse than 92.56% of its industry peers.
INVZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.43
ROIC/WACCN/A
WACC9.36%

2.3 Liquidity

A Current Ratio of 3.64 indicates that INVZ has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.64, INVZ is in the better half of the industry, outperforming 66.94% of the companies in the same industry.
A Quick Ratio of 3.59 indicates that INVZ has no problem at all paying its short term obligations.
INVZ's Quick ratio of 3.59 is amongst the best of the industry. INVZ outperforms 80.17% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.59

7

3. Growth

3.1 Past

INVZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.43%, which is quite impressive.
Looking at the last year, INVZ shows a very strong growth in Revenue. The Revenue has grown by 339.59%.
Measured over the past years, INVZ shows a very strong growth in Revenue. The Revenue has been growing by 222.33% on average per year.
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)339.59%
Revenue growth 3YN/A
Revenue growth 5Y222.33%
Sales Q2Q%29.77%

3.2 Future

The Earnings Per Share is expected to grow by 30.85% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 131.58% on average over the next years. This is a very strong growth
EPS Next Y33.28%
EPS Next 2Y17.61%
EPS Next 3Y2.19%
EPS Next 5Y30.85%
Revenue Next Year40.93%
Revenue Next 2Y120.32%
Revenue Next 3Y143.07%
Revenue Next 5Y131.58%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

INVZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year INVZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.61%
EPS Next 3Y2.19%

0

5. Dividend

5.1 Amount

INVZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INNOVIZ TECHNOLOGIES LTD

NASDAQ:INVZ (12/31/2024, 8:00:02 PM)

Premarket: 1.68 0 (0%)

1.68

-0.16 (-8.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)N/A N/A
Inst Owners33.46%
Inst Owner Change-9.2%
Ins Owners2.06%
Ins Owner ChangeN/A
Market Cap283.38M
Analysts76
Price Target2.06 (22.62%)
Short Float %6.08%
Short Ratio2.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.79%
Min EPS beat(2)-6.56%
Max EPS beat(2)16.15%
EPS beat(4)2
Avg EPS beat(4)-1.8%
Min EPS beat(4)-20.87%
Max EPS beat(4)16.15%
EPS beat(8)3
Avg EPS beat(8)-1.28%
EPS beat(12)5
Avg EPS beat(12)-1.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)20.7%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)42.03%
Revenue beat(4)3
Avg Revenue beat(4)23.88%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)42.03%
Revenue beat(8)5
Avg Revenue beat(8)9.68%
Revenue beat(12)5
Avg Revenue beat(12)-4.75%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.57%
PT rev (3m)-12.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20.18%
EPS NY rev (1m)-2.49%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-55.22%
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-13.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.55
P/FCF N/A
P/OCF N/A
P/B 3.06
P/tB 3.06
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.2
BVpS0.55
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -73.85%
ROE -115.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.97%
ROA(5y)-63.9%
ROE(3y)-66%
ROE(5y)-85.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.51%
Cap/Sales 11.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.64
Quick Ratio 3.59
Altman-Z -5.43
F-Score5
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)156.39%
Cap/Depr(5y)202.39%
Cap/Sales(3y)158.31%
Cap/Sales(5y)179.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y33.28%
EPS Next 2Y17.61%
EPS Next 3Y2.19%
EPS Next 5Y30.85%
Revenue 1Y (TTM)339.59%
Revenue growth 3YN/A
Revenue growth 5Y222.33%
Sales Q2Q%29.77%
Revenue Next Year40.93%
Revenue Next 2Y120.32%
Revenue Next 3Y143.07%
Revenue Next 5Y131.58%
EBIT growth 1Y16.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.27%
EBIT Next 3Y9.16%
EBIT Next 5Y12.03%
FCF growth 1Y25.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.86%
OCF growth 3YN/A
OCF growth 5YN/A